💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Catalyst Pharmaceutical Partners, Inc. (CPRX)
« Back to company indexCPRX Chatter Timeline
Stock Ticker for CPRX
Most Active Tweeters for CPRX
| User | Tweets |
|---|---|
| @sbwcws | 9 |
| @meek_flexin | 3 |
| @mediasentiment | 3 |
| @Tickeron | 3 |
| @bbiittccooiinn | 2 |
Recent Tweets for CPRX
 |
@ibracadabra_S Sold half my $CPRX & bought $OCGN... I need some movement January 19th 2021, 6:01pm |
 |
@ShortAlgoKing $CPRX [Buy Alert] Signals could not be any clearer on the 5-minute chart of CPRX with the entry / exit indicators f… https://t.co/lHdJZ4OG9R January 19th 2021, 4:01pm |
 |
@astockwatch1 ticker symbol $CPRX Catalyst Pharma sees FY20 revenue as high as $118M, provides update on product expansion… https://t.co/iVz6hgjnJb January 18th 2021, 1:01pm |
 |
@TexMexboy117 @ShortSqueezed1 can your thoughts on $CPRX? January 13th 2021, 3:01pm |
 |
@rmacmillan310 $CPRX might be worth taking a position when this bottoms 2.46 % change recently https://t.co/KT0faIAR6D January 13th 2021, 1:01pm |
 |
@gcassidy718 $CPRX wow what a great surprise 2.46 % https://t.co/cjDg2jzMhO January 13th 2021, 12:01pm |
 |
@CrowningProfits Took some $CPRX $ 3.50. I like the risk reward at this level. https://t.co/8oo8Ujyrz8 January 12th 2021, 5:01pm |
 |
@Tickeron $CPRX's price moved above its 50-day Moving Average on January 4, 2021. View odds for this and other indicators:… https://t.co/y10YT98lmA January 10th 2021, 8:01am |
 |
@MarketFollows 3 Top Small-Cap Stocks to Buy in January $CPRX https://t.co/XoqgYkGfwC $SPY January 10th 2021, 1:01am |
 |
@Gambiste1 RT @financeasmr: Catalyst Pharmaceuticals $CPRX "a small commercial-stage biotech whose primary therapy, Firdapse, treats a rare autoimmu… January 9th 2021, 8:01pm |
 |
@financeasmr Catalyst Pharmaceuticals $CPRX "a small commercial-stage biotech whose primary therapy, Firdapse, treats a rare a… https://t.co/8vsGDPzkur January 9th 2021, 7:01pm |
 |
@stocknewsdotcom $CPRX The Robinhood app is popular among millennial investors. And as the Covid-19 pandemic focused attention on t… https://t.co/c8mfonayCe January 8th 2021, 2:01pm |
 |
@mediasentiment $CPRX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 391 January 8th 2021, 7:01am |
|
@mediasentiment $CPRX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 377 January 8th 2021, 7:01am |
|
@Tickeron $CPRX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/5oEj8IQ4hy January 8th 2021, 6:01am |
 |
@meek_flexin @BahamaBen9 @Gambiste1 $CPRX ? January 7th 2021, 11:01pm |
|
@ibracadabra_S @meek_flexin @umarashraf28 $CPRX - the stock never moves !! January 7th 2021, 10:01pm |
 |
@DopeNaturale My entry wasn’t that great but I’m glad to finally see some upward movement $CPRX January 7th 2021, 3:01pm |
|
@meek_flexin @umarashraf28 I’d suggest putting some gains in $CPRX looks like it’s getting ready to run , $INO strong consolidat… https://t.co/O8izDnVlrg January 7th 2021, 12:01pm |
 |
@vetris_stocks $CPRX A ONE AND ONLY patented drug pharma company going for a song https://t.co/54Se65Nww0 January 7th 2021, 9:01am |
 |
@sbwcws Piper says Catalyst's Firdapse commercial business performing as expected $CPRX January 7th 2021, 8:01am |
|
@meek_flexin @umarashraf28 Interested to see how you feel about $CPRX $INO January 6th 2021, 11:01pm |
 |
@newsfilterio Catalyst Pharma sees FY20 revenue as high as $118M, provides update on product expansion $CPRX https://t.co/9lyyMTHDhR January 6th 2021, 10:01pm |
 |
@bbiittccooiinn $CPRX #NASDAQ 8-K - CATALYST PHARMACEUTICALS, INC. [B/A=0/0 - Bid/Ask Size=0/0 Volume=2,315,745 AverageVol=1,91… https://t.co/Nz8ZjMmsy3 January 6th 2021, 9:01pm |
 |
@EdgarInsider A Form 8-K [Press/News Current Report] filing has been made with the SEC: $CPRX #CatalystPharmaceuticals, Inc https://t.co/yc2cCCXymI January 6th 2021, 4:01pm |
 |
@theflynews Catalyst Firdapse commercial business performing as expected, says Piper Sandler $CPRX https://t.co/gBRZxB4zkT January 6th 2021, 4:01pm |
 |
@fintel_io Also, if you are new to $CPRX here's a background article on Finpedia for you https://t.co/Dc5MFjlUWb January 6th 2021, 4:01pm |
|
@fintel_io $CPRX / Catalyst Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Other Events - FORM 8-K https://t.co/PP8lDoSETu January 6th 2021, 4:01pm |
|
@sbwcws Catalyst Firdapse commercial business performing as expected, says Piper Sandler $CPRX January 6th 2021, 3:01pm |
|
@Tickeron $CPRX's price moved above its 50-day Moving Average on January 4, 2021. View odds for this and other indicators:… https://t.co/4EnKVA1qzm January 6th 2021, 3:01pm |
|
@rmacmillan310 $CPRX I’ll probably buy on the dip. Still need to do more research. -4.11 % https://t.co/KT0faIAR6D January 6th 2021, 2:01pm |
|
@bbiittccooiinn $CPRX #NASDAQ News: Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term… https://t.co/kxZ64MDDzo January 6th 2021, 1:01pm |
 |
@Briefingcom $CPRX: Catalyst Pharma announces strategic plan for product portfolio expansion and provides corporate update https://t.co/obcIVf0KHB January 6th 2021, 10:01am |
 |
@MarcJacksonLA $CPRX Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and P… https://t.co/0YbSxFpaRD January 6th 2021, 9:01am |
|
@sbwcws Catalyst Pharmaceuticals awaiting schedule or decision in FDA suit $CPRX January 6th 2021, 8:01am |
|
@sbwcws Catalyst Pharmaceuticals decides not to pursue Kennedy's disease indication $CPRX January 6th 2021, 8:01am |
|
@sbwcws Catalyst Pharmaceuticals decides not to pursue SMA Type 3 indication $CPRX January 6th 2021, 8:01am |
|
@sbwcws Catalyst plans to present hypotheses on MuSK-MG Phase 3 trial to FDA in 1H21 $CPRX January 6th 2021, 8:01am |
|
@sbwcws Catalyst Pharmaceuticals expects additional PK work on Firdapse LA in 2021 $CPRX January 6th 2021, 8:01am |
|
@sbwcws Catalyst Pharmaceuticals sees 2020 Firdapse revenues approx. $118M $CPRX January 6th 2021, 8:01am |
|
@sbwcws Catalyst expands focus to earlier stage programs, validated tech platforms $CPRX January 6th 2021, 8:01am |
 |
@Beeken_health $CPRX - Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and… https://t.co/wlodgYOVpg January 6th 2021, 8:01am |
 |
@Allstocknews $CPRX Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success From our Stock News Alerts App January 6th 2021, 8:01am |
 |
@FlashAlert_me $CPRX [15s. delayed]: Issued Press Release on January 06, 08:07:00: Catalyst Pharmaceuticals Announces Strategic Pl… https://t.co/5VBkhdBABU January 6th 2021, 8:01am |
 |
@kevinjaybe $CPRX Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update January 6th 2021, 8:01am |
 |
@TheTradeXchange $CPRX: Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update January 6th 2021, 8:01am |
|
@Testson15 $CPRX: Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate January 6th 2021, 8:01am |
 |
@stock_titan $CPRX Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and P… https://t.co/6oawFvMD4M January 6th 2021, 8:01am |
 |
@TrdngDrivatives RT @mediasentiment: $CPRX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 128 January 6th 2021, 5:01am |
|
@mediasentiment $CPRX new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 128 January 6th 2021, 4:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
- ✓ Patent Expirations and Generic Entry
- ✓ 505(b)(2) & Biosimilars
- ✓ Insightful Articles and Case Studies
- ✓ Patent Litigation & Challenges
- ✓ Industry Trends
